A Novel α4/7-Conotoxin QuIA Selectively Inhibits α3β2 and α6/α3β4 Nicotinic Acetylcholine Receptor Subtypes with High Efficacy

A Novel α4/7-Conotoxin QuIA Selectively Inhibits α3β2 and α6/α3β4 Nicotinic Acetylcholine Receptor Subtypes with High Efficacy

α6β4 nAChR is expressed in the peripheral and central nervous systems and is associated with pain, addiction, and movement disorders. Natural α-conotoxins (α-CTxs) can effectively block different nAChR subtypes with higher efficacy and selectivity. However, the research on α6β4 nAChR is relatively p...

Full description

Bibliographic Details
Main Authors:	Liujun Wang, Xixi Wu, Xiaopeng Zhu, Dongting Zhangsun, Yong Wu, Sulan Luo
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Marine Drugs
Subjects:	α-conotoxin QuIA nicotinic acetylcholine receptor two-electrode voltage clamp α3β2 nAChR α6β4 nAChR
Online Access:	https://www.mdpi.com/1660-3397/20/2/146

Similar Items

α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice
by: Xiaodan Li, et al.
Published: (2020-12-01)

Fluorescently Labeled α-Conotoxin TxID, a New Probe for α3β4 Neuronal Nicotinic Acetylcholine Receptors
by: Meiling Huang, et al.
Published: (2022-08-01)

Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor
by: Jie Ren, et al.
Published: (2018-06-01)

Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB
by: Xincan Li, et al.
Published: (2020-03-01)

Characterization of an α 4/7-Conotoxin LvIF from <i>Conus lividus</i> That Selectively Blocks α3β2 Nicotinic Acetylcholine Receptor
by: Man Guo, et al.
Published: (2021-07-01)

<i>In Silico</i> Finding of Key Interaction Mediated α3β4 and α7 Nicotinic Acetylcholine Receptor Ligand Selectivity of Quinuclidine-Triazole Chemotype
by: Kuntarat Arunrungvichian, et al.
Published: (2020-08-01)

Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID
by: Jianying Dong, et al.
Published: (2023-05-01)

Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors
by: Thao NT Ho, et al.
Published: (2023-04-01)

Interactions of Globular and Ribbon [γ4E]GID with α4β2 Neuronal Nicotinic Acetylcholine Receptor
by: Xiaosa Wu, et al.
Published: (2021-08-01)

Recombinant Expression and Characterization of α-Conotoxin LvIA in Escherichia coli
by: Xiaopeng Zhu, et al.
Published: (2016-01-01)

Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors
by: Ayaulym Bekbossynova, et al.
Published: (2021-06-01)

Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors
by: Victor S. Batista, et al.
Published: (2022-11-01)

The Allosteric Activation of α7 nAChR by α-Conotoxin MrIC Is Modified by Mutations at the Vestibular Site
by: Alican Gulsevin, et al.
Published: (2021-08-01)

α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
by: Huiyang Liu, et al.
Published: (2023-03-01)

αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors
by: Zhihua Sun, et al.
Published: (2020-04-01)

Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively
by: Alessandro Giraudo, et al.
Published: (2023-07-01)

αO-Conotoxin GeXIVA[1,2] Reduced Neuropathic Pain and Changed Gene Expression in Chronic Oxaliplatin-Induced Neuropathy Mice Model
by: Huanbai Wang, et al.
Published: (2024-01-01)

α-Conotoxin as Potential to α7-nAChR Recombinant Expressed in <i>Escherichia coli</i>
by: Yanli Liu, et al.
Published: (2020-08-01)

Using Constellation Pharmacology to Characterize a Novel α-Conotoxin from <i>Conus ateralbus</i>
by: Jorge L. B. Neves, et al.
Published: (2024-02-01)

Molecular Regulation of Betulinic Acid on α3β4 Nicotinic Acetylcholine Receptors
by: Shinhui Lee, et al.
Published: (2021-05-01)

Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment
by: Xiaoyu Zhu, et al.
Published: (2022-08-01)

Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages
by: Yao Tan, et al.
Published: (2022-03-01)

Rare Missense Variants of the Human β4 Subunit Alter Nicotinic α3β4 Receptor Plasma Membrane Localisation
by: Sara Francesca Colombo, et al.
Published: (2023-01-01)

Activation of the α7 Nicotinic Acetylcholine Receptor Prevents against Microglial-Induced Inflammation and Insulin Resistance in Hypothalamic Neuronal Cells
by: Camila Libardi do Amaral, et al.
Published: (2022-07-01)

<span style="font-variant: small-caps">d</span>-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability
by: Jie Ren, et al.
Published: (2019-02-01)

Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders
by: Chien-Hsing Lee, et al.
Published: (2022-12-01)

Activation of α7nAChR by PNU282987 improves cognitive impairment through inhibiting oxidative stress and neuroinflammation in D-galactose induced aging via regulating α7nAChR/Nrf2/HO-1 signaling pathway
by: Yawen Zhang, et al.
Published: (2023-05-01)

The Constitutive Lack of α7 Nicotinic Receptor Leads to Metabolic Disorders in Mouse
by: Blandine Gausserès, et al.
Published: (2020-07-01)

Diminished α7 nicotinic acetylcholine receptor (α7nAChR) rescues amyloid-β induced atrial remodeling by oxi-CaMKII/MAPK/AP-1 axis-mediated mitochondrial oxidative stress
by: Jikai Zhao, et al.
Published: (2023-02-01)

RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3<sup>+</sup> T-Cells
by: Peter N. Huynh, et al.
Published: (2022-11-01)

Structural Insights into the Role of β3 nAChR Subunit in the Activation of Nicotinic Receptors
by: Petros Giastas, et al.
Published: (2022-07-01)

Swimming exercise and clove oil can improve memory by molecular responses modification and reduce dark cells in rat model of Alzheimer's disease
by: Z. Gorgin Karaji, et al.
Published: (2023-06-01)

Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression
by: Mong-Lien Wang, et al.
Published: (2020-09-01)

Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson’s Disease is Mediated by α7-Nicotinic Receptors
by: Eslam El Nebrisi, et al.
Published: (2020-10-01)

Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing Immunosuppression
by: Andrei E. Siniavin, et al.
Published: (2020-03-01)

Target identification and validation of the alpha7 nicotinic acetylcholine receptor as a potential therapeutic target in retinal disease
by: David M. Linn
Published: (2023-07-01)

Nicotine Increases Macrophage Survival through α7nAChR/NF-κB Pathway in <i>Mycobacterium</i> <i>avium</i> <i>paratuberculosis</i> Infection
by: Dania AlQasrawi, et al.
Published: (2021-05-01)

Analogs of 6-Bromohypaphorine with Increased Agonist Potency for α7 Nicotinic Receptor as Anti-Inflammatory Analgesic Agents
by: Igor A. Ivanov, et al.
Published: (2023-06-01)

Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA
by: Zhihua Sun, et al.
Published: (2020-01-01)

Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human α3β4 Nicotinic Acetylcholine Receptor
by: Yuan Ma, et al.
Published: (2022-07-01)